Vericel Corporation (VCEL) stock analysis
VCEL · Vericel Corporation
Latest recorded price: USD 57.48
Model-estimated fair value: USD 8.11. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Biotechnology
At $57.48, VCEL trades 608.6% above the model's base-case value of $8.11. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $6.90 in the conservative case and $9.62 in the optimistic case, with a valuation confidence score of 78/100. About 81% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 18.9%, free cash flow margin 9.0%, ROIC 4.7%. The model flags 2 risk signals for this company.